1. Home
  2. RVMDW vs DKL Comparison

RVMDW vs DKL Comparison

Compare RVMDW & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMDW
  • DKL
  • Stock Information
  • Founded
  • RVMDW N/A
  • DKL 2012
  • Country
  • RVMDW United States
  • DKL United States
  • Employees
  • RVMDW 443
  • DKL N/A
  • Industry
  • RVMDW
  • DKL Natural Gas Distribution
  • Sector
  • RVMDW
  • DKL Energy
  • Exchange
  • RVMDW Nasdaq
  • DKL Nasdaq
  • Market Cap
  • RVMDW N/A
  • DKL N/A
  • IPO Year
  • RVMDW N/A
  • DKL N/A
  • Fundamental
  • Price
  • RVMDW $0.53
  • DKL $38.28
  • Analyst Decision
  • RVMDW
  • DKL Buy
  • Analyst Count
  • RVMDW 0
  • DKL 4
  • Target Price
  • RVMDW N/A
  • DKL $43.00
  • AVG Volume (30 Days)
  • RVMDW N/A
  • DKL 195.5K
  • Earning Date
  • RVMDW N/A
  • DKL 11-06-2024
  • Dividend Yield
  • RVMDW N/A
  • DKL 11.55%
  • EPS Growth
  • RVMDW N/A
  • DKL N/A
  • EPS
  • RVMDW N/A
  • DKL 2.83
  • Revenue
  • RVMDW N/A
  • DKL $984,922,000.00
  • Revenue This Year
  • RVMDW N/A
  • DKL $0.55
  • Revenue Next Year
  • RVMDW N/A
  • DKL $5.17
  • P/E Ratio
  • RVMDW N/A
  • DKL $13.48
  • Revenue Growth
  • RVMDW N/A
  • DKL N/A
  • 52 Week Low
  • RVMDW N/A
  • DKL $37.02
  • 52 Week High
  • RVMDW N/A
  • DKL $53.80
  • Technical
  • Relative Strength Index (RSI)
  • RVMDW N/A
  • DKL 39.72
  • Support Level
  • RVMDW N/A
  • DKL $38.80
  • Resistance Level
  • RVMDW N/A
  • DKL $40.16
  • Average True Range (ATR)
  • RVMDW 0.00
  • DKL 0.70
  • MACD
  • RVMDW 0.00
  • DKL 0.06
  • Stochastic Oscillator
  • RVMDW 0.00
  • DKL 21.99

About RVMDW Revolution Medicines Inc. Warrant

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Share on Social Networks: